Safety signals with faricimab in routine practice, including intraocular inflammation and endophthalmitis, aligned with prior ...

A new study published in the Journal of the American Medical Association found that administration of anti–vascular ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the ...

Anti-VEGF drugs are associated with kidney injury for some patients, but no particular anti-VEGF has a stronger association than any others. The risk of kidney failure for people who receive ...

VLTR-559 demonstrates sustained anti-VEGF activity and favorable safety at target clinical dosefor treatment of wetage-related macular ...

In patients with proliferative diabetic retinopathy, treatment with anti–vascular endothelial growth factor (anti-VEGF) may offer a safer alternative to panretinal photocoagulation (PRP), leading to ...

Of three anti-vascular endothelial growth factor (VEGF) drugs used to treat several serious eye diseases, there was no substantially different relative risk for kidney failure, a retrospective cohort ...

Please provide your email address to receive an email when new articles are posted on . One specialist proposed that new-generation anti-VEGFs show better efficacy. Another said there is a lack of ...

Please provide your email address to receive an email when new articles are posted on . SEATTLE — In this Healio Video Perspective from the ARVO meeting, Jennifer I. Lim, MD, discusses anti-VEGF ...

At the 131st Congress of the French Society of Ophthalmology in Paris, France, the role of second-generation intravitreal anti-VEGF injections compared to corticosteroid injections in treating ...